Question 1

Does Goldman Sachs own CTNM stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Goldman Sachs holds 497,255 shares of CTNM (Contineum Therapeutics), worth $8.2M.

Question 2

How many shares of CTNM does Goldman Sachs own?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs holds 497,255 shares of CTNM (Contineum Therapeutics).

Question 3

What is Goldman Sachs' CTNM position worth?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs' CTNM position is worth $8.2M.

Question 4

Is Goldman Sachs buying or selling CTNM?

Accepted Answer

In Q2 2026, Goldman Sachs increased its CTNM position by 190,147 shares (+61.9%).

Question 5

When did Goldman Sachs first buy CTNM?

Accepted Answer

Goldman Sachs first reported CTNM in its Q4 2024 13F and has listed it in 7 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	497,255	+61.9%	$8.2M	0.0%	$16.39	40
2026-Q1	Increased	307,108	+190.8%	$4M	0.0%	$14.10	43
2025-Q4	Increased	105,594	+250.4%	$1.2M	0.0%	$11.40	41
2025-Q3	Decreased	30,135	-50.5%	$354,086	0.0%	$11.82	0
2025-Q2	Increased	60,922	+328.4%	$241,860	0.0%	$4.11	25
2025-Q1	Decreased	14,221	-46.1%	$99,263	0.0%	$7.07	0
2024-Q4	New	26,365	-	$386,247	0.0%	$14.47	33

CTNM7 quarters

CTNM
7 quarters